Vol. 6 Issue 3

The expanding arena of emerging drugs, increased sensitivity to clinical outcomes and healthcare costs are driving the need for alternative drug delivery methods and devices.

Peptide and protein drugs have found an important position in therapeutics.

The pharmaceutical sector is a major user of the patent system.

While only a small - and declining - number of new chemical entities are approved annually, thousands of patents are applied for to protect variants of existing products, processes of manufacture or, where admitted, second indications of known pharmaceutical products.

Researchers have discovered that rifampicin, an antibiotic used to treat tuberculosis and leprosy, inhibit the formation of alpha synuclein fibrils that have already formed.

Because the aggregation of alpha synuclein in dopaminergic neuron is critical steps in pathogenesis of Parkinson’s disease (PD). Rifampicin or a related compound could provide a new approach to the treatment of PD.

Lantana camara Linn. is a significant weed of which there are some 650 varieties in over 60 countries or island groups.

It is established and expanding in many regions of the world, often as a result of clearing of forest for timber or agriculture. It impacts severely on agriculture as well as on natural ecosystems.

What are “Me-Too” Drugs? ^{1, 2} : The Process of new drug development is complicated, time-consuming and expensive.

Pithecellobium species (leguminosae) are widely distributed in the tropics, chiefly in Asia and America.

Tarun Kumar Satpathy

Diabetes is a complex and heterogeneous disorder presently affecting more than 100 million people worldwide and causing serious socio-economic problems.

Appropriate experimental models are essential tools for understanding the pathogenesis, complications, and genetic or environmental influences that increase the risks of type 2 diabetes and testing of various therapeutic agents.

Mukesh T. Mohite